Aoyuan Healthy Life Group Company Limited

HKEX:3662.HK

0.465 (HKD) • At close November 13, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q4
Revenue 350.023350.023388.235388.235393.27393.27391.584391.584423.292423.292468.93468.93501.944501.944430.599430.599274.172274.172254.42254.42195.981195.981175.914175.609133.656133.656156.501
Cost of Revenue 240.666240.666290.073290.073291.622291.622314.573314.573301.696301.696408.018408.018328.068328.068299.667299.667163.695163.695163.444163.444118.429118.429108.17131.32685.29385.293117.281
Gross Profit 109.357109.35798.16398.163101.648101.64877.01177.011121.597121.59760.91260.912173.876173.876130.932130.932110.477110.47790.97690.97677.55277.55267.74444.28348.36348.36339.22
Gross Profit Ratio 0.3120.3120.2530.2530.2580.2580.1970.1970.2870.2870.130.130.3460.3460.3040.3040.4030.4030.3580.3580.3960.3960.3850.2520.3620.3620.251
Reseach & Development Expenses 00000000000000000000001.40000
General & Administrative Expenses 21.2621.2631.79631.79632.54232.54230.27130.27152.49952.49946.66346.66346.25446.25443.19243.19229.57829.57838.37538.37522.94222.94278.791-17.00718.11318.1136.609
Selling & Marketing Expenses 0.8310.8310.4920.4920.1380.1380.4510.4510.1970.1971.4671.4671.4121.4120.8430.8430.3310.3310.5470.5470.6880.6880.7130.3070.1560.1560.272
SG&A 62.43762.43736.45836.45875.15675.15627.66527.665104.104104.104187.237187.23755.48855.48852.95952.95931.79431.79441.78741.78724.20924.20979.504-16.718.71318.7136.881
Other Expenses 0000000000000000000000-36.3736.370016.095
Operating Expenses 62.43762.43736.45848.1759.759.79.1999.19985.57885.578264.801264.80147.747.743.08343.08328.40628.40639.68739.68720.77920.77943.13419.6721.96521.96522.976
Operating Income 46.9246.9261.70561.70526.49226.49249.34749.34717.49317.493-126.325-126.325118.388118.38877.97377.97378.68378.68349.18949.18953.34353.34324.09531.43929.6529.6516.334
Operating Income Ratio 0.1340.1340.1590.1590.0670.0670.1260.1260.0410.041-0.269-0.2690.2360.2360.1810.1810.2870.2870.1930.1930.2720.2720.1370.1790.2220.2220.104
Total Other Income Expenses Net 3.1343.134-8.167-8.16717.2617.2618.85918.85914.10114.101-81.37-81.372.1642.1645.225.220.9040.9042.3172.3174.4594.4590.5825.718-3.164-3.164-0.221
Income Before Tax 50.05350.05353.53853.53843.75243.75268.20668.20631.59431.594-207.695-207.695120.552120.55283.19283.19279.58679.58651.50651.50657.80157.80125.19230.33126.48626.48616.023
Income Before Tax Ratio 0.1430.1430.1380.1380.1110.1110.1740.1740.0750.075-0.443-0.4430.240.240.1930.1930.290.290.2020.2020.2950.2950.1430.1730.1980.1980.102
Income Tax Expense 12.50412.50413.29413.2949.3919.39112.49112.4915.7275.72716.06916.06927.56927.56912.52512.52523.77523.77514.97614.97612.77612.7765.9826.9148.6728.6725.69
Net Income 40.82440.82446.95946.95931.6131.6155.48255.48224.72224.722-184.531-184.53189.06189.06169.65169.65155.52255.52236.26936.26944.97144.97119.14523.28317.85817.85810.278
Net Income Ratio 0.1170.1170.1210.1210.080.080.1420.1420.0580.058-0.394-0.3940.1770.1770.1620.1620.2030.2030.1430.1430.2290.2290.1090.1330.1340.1340.066
EPS 0.0560.0560.0650.0650.0440.0440.0760.0760.0340.034-0.25-0.250.120.120.0960.0960.0760.0770.050.050.070.070.0270.0330.0430.0430.015
EPS Diluted 0.0560.0560.0650.0650.0440.0440.0760.0760.0340.034-0.25-0.250.120.120.0960.0960.0770.0770.050.050.070.070.0270.0330.0430.0430.015
EBITDA 51.17451.17468.29468.29430.97830.97855.8155.8122.9822.98-118.677-118.677124.467124.46784.67384.67381.0181.0151.92251.92254.90254.90229.80632.43530.50730.50717.056
EBITDA Ratio 0.1460.1460.1760.1760.0790.0790.1430.1430.0540.054-0.253-0.2530.2480.2480.1970.1970.2950.2950.2040.2040.280.280.1430.1850.2280.2280.109